Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients

NCT06329674 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

235

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes

Interventions

DRUG: AJU-A51
DRUG: A51R2
DRUG: A51R3
DRUG: AJU-A51 Placebo
DRUG: A51R2 Placebo

Sponsor

AJU Pharm Co., Ltd.